News + Filings Holdings
|
|
VHCP Management, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
HERON THERAPEUTICS, INC. /DE/
| HRTX | Common | 1,095,734 | 0 | 14,354,000 | -4,525,000 | 15.43 | 2.80 |
Hist
| 12/31/2016 |
|
Coherus BioSciences, Inc.
| CHRS | Common | 305,505 | 0 | 8,600,000 | 419,000 | 9.25 | 0.70 |
Hist
| 12/31/2016 |
|
BIOCRYST PHARMACEUTICALS INC
| BCRX | Common | 1,155,104 | 150,000 | 7,312,000 | 2,879,000 | 7.86 | 1.57 |
Hist
| 12/31/2016 |
|
AVADEL PHARMACEUTICALS PLC
| FLML | SPONSORED ADR | 500,000 | 0 | 5,195,000 | -1,005,000 | 5.59 | 1.21 |
Hist
| 12/31/2016 |
|
Ra Pharmaceuticals, Inc.
| RARX | Common | 232,500 | 232,500 | 3,532,000 | 3,532,000 | 3.80 | 1.03 |
Hist
| 12/31/2016 |
|
Adverum Biotechnologies, Inc.
| ADVM | COM | 1,102,735 | 0 | 3,198,000 | -1,334,000 | 3.44 | 2.64 |
Hist
| 12/31/2016 |
|
Lipocine Inc.
| LPCN | COM | 849,921 | 0 | 3,128,000 | -663,000 | 3.36 | 4.65 |
Hist
| 12/31/2016 |
|
CoLucid Pharmaceuticals, Inc.
| CLCD | COM | 68,190 | 0 | 2,482,000 | -119,000 | 2.67 | 0.35 |
Hist
| 12/31/2016 |
|
Sio Gene Therapies Inc.
| AXON | Common | 184,110 | 0 | 2,287,000 | -291,000 | 2.46 | 0.19 |
Hist
| 12/31/2016 |
|
Ocera Therapeutics, Inc.
| OCRX | Common | 912,050 | 55,500 | 1,915,000 | -346,000 | 2.06 | 3.94 |
Hist
| 12/31/2016 |
|
Ascendis Pharma A/S
| ASND | SPONSORED ADR | 90,000 | 0 | 1,822,000 | 13,000 | 1.96 | |
Hist
| 12/31/2016 |
|
PDS Biotechnology Corp
| EDGE | COM | 135,000 | 0 | 1,688,000 | 283,000 | 1.82 | 0.47 |
Hist
| 12/31/2016 |
|
STEMLINE THERAPEUTICS INC
| STML | Common | 135,420 | 0 | 1,449,000 | -18,000 | 1.56 | 0.71 |
Hist
| 12/31/2016 |
|
ALCOBRA LTD.
| ADHD | SHS | 658,910 | 0 | 1,384,000 | -244,000 | 1.49 | |
Hist
| 12/31/2016 |
|
ARCA biopharma, Inc.
| ABIO | Common | 462,399 | 0 | 1,318,000 | 9,000 | 1.42 | 5.09 |
Hist
| 12/31/2016 |
|
Akari Therapeutics Plc
| AKTX | SPONSORED ADR | 158,352 | 0 | 1,115,000 | -233,000 | 1.20 | |
Hist
| 12/31/2016 |
|
CytomX Therapeutics, Inc.
| CTMX | Common | 64,200 | 0 | 706,000 | -301,000 | 0.76 | 0.18 |
Hist
| 12/31/2016 |
|
Audentes Therapeutics, Inc.
| BOLD | STOCK | 15,000 | 0 | 274,000 | 7,000 | 0.29 | 0.07 |
Hist
| 12/31/2016 |
|
Sierra Oncology, Inc.
| DNAI | COMMON | 56,056 | 0 | 84,000 | -18,000 | 0.09 | 0.18 |
Hist
| 12/31/2016 |
|
Aeglea BioTherapeutics, Inc.
| AGLE | COM | 6,000 | 0 | 26,000 | -12,000 | 0.03 | 0.04 |
Hist
| 12/31/2016 |
|
Larimar Therapeutics, Inc.
| ZFGN | Common | 0 | -602,114 | 0 | -1,993,000 | 0.00 | 0.00 |
Hist
| 12/31/2016 |
|
ACHILLION PHARMACEUTICALS INC
| ACHN | Common | 0 | -180,000 | 0 | -1,458,000 | 0.00 | 0.00 |
Hist
| 12/31/2016 |
|
BeiGene, Ltd.
| BGNE | ADR | 0 | -51,000 | 0 | -1,571,000 | 0.00 | 0.00 |
Hist
| 12/31/2016 |
|
REGENXBIO Inc.
| RGNX | COM | 0 | -24,089 | 0 | -337,000 | 0.00 | 0.00 |
Hist
| 12/31/2016 |
|
|
|
|